Avanos Medical
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
6.325.635.10
Price/Sales ratio
0.750.710.68
Earnings per Share (EPS)
$1.80$2.03$2.24

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
78.08-3.6543.2927.0936.76-34.94-80.62264.7025.13-16.9128.23-34.94
Price/Sales ratio
1.260.981.083.513.242.293.062.231.541.551.712.29
Price/Book Value ratio
1.411.471.561.761.621.261.741.310.980.841.081.26
Price/Cash Flow ratio
14.3015.949.1214.89-14.51-21.53-877.2219.1013.9632.2615.46-14.51
Price/Free Cash Flow ratio
30.4857.2210.7921.27-10.85-12.82-96.6125.1517.7271.5919.63-10.85
Price/Earnings Growth ratio
-0.940.00-0.390.27-1.320.191.98-2.150.030.070.03-1.32
Dividend Yield
32.13%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
32.80%33.76%35.03%55.08%59.92%57.65%52.22%48.92%54.87%56.39%54.76%57.65%
Operating Profit Margin
5.63%-23.99%5.48%-7.04%0.07%-7.98%-6.44%1.19%9.02%0.62%8.91%0.07%
Pretax Profit Margin
5.45%-26.07%3.47%-11.80%-2.77%-9.17%-8.46%0.77%7.95%-1.17%7.84%-2.77%
Net Profit Margin
1.62%-27.07%2.49%12.96%8.81%-6.57%-3.80%0.84%6.15%-9.17%6.07%6.07%
Effective Tax Rate
70.28%-3.84%28.02%55.54%53.03%28.28%55.04%10.34%22.54%-25.31%22.55%28.28%
Return on Assets
1.07%-21.31%1.92%3.61%3.13%-2.55%-1.62%0.39%2.82%-3.65%2.78%2.78%
Return On Equity
1.81%-40.39%3.61%6.52%4.43%-3.62%-2.16%0.49%3.91%-4.99%3.93%3.93%
Return on Capital Employed
4.34%-22.41%5.00%-2.38%0.03%-3.50%-3.06%0.61%4.62%0.28%4.56%0.03%
Liquidity Ratios
Current Ratio
1.922.141.822.972.692.532.80N/AN/AN/A2.682.53
Quick Ratio
1.121.180.982.742.241.841.791.921.661.381.591.84
Cash ratio
0.410.410.350.561.450.960.670.850.680.370.680.96
Days of Sales Outstanding
51.0552.0943.20121.1484.2185.7085.7357.9474.7377.4174.7385.70
Days of Inventory outstanding
91.97106.1296.15121.04169.51180.27180.52144.25187.72202.88187.27169.51
Operating Cycle
143.03158.21139.36242.19253.72265.97266.25202.19262.46280.30205.70265.97
Days of Payables Outstanding
54.8057.1256.66227.47237.23102.5572.2554.1366.9869.9966.81102.55
Cash Conversion Cycle
88.22101.0982.6914.7116.49163.42194.00148.06195.48210.3054.0916.49
Debt Ratios
Debt Ratio
0.250.280.270.260.130.140.110.090.130.100.270.13
Debt Equity Ratio
0.420.540.520.470.190.200.150.110.180.140.380.19
Long-term Debt to Capitalization
0.290.350.340.300.160.160.120.090.140.110.160.16
Total Debt to Capitalization
0.290.350.340.320.160.170.130.100.150.120.170.16
Interest Coverage Ratio
15.712.902.67-1.360.01-3.71-2.95N/AN/AN/A7.310.01
Cash Flow to Debt Ratio
0.230.160.320.24-0.58-0.28-0.010.600.390.170.32-0.58
Company Equity Multiplier
1.691.891.871.801.411.421.331.261.381.361.381.42
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.080.060.110.23-0.22-0.10-0.000.110.110.040.11-0.22
Free Cash Flow / Operating Cash Flow Ratio
0.460.270.840.701.331.679.080.750.780.450.781.67
Cash Flow Coverage Ratio
0.230.160.320.24-0.58-0.28-0.010.600.390.170.32-0.58
Short Term Coverage Ratio
37.92N/AN/A3.62N/A-5.06-0.165.9314.661.514.78-5.06
Dividend Payout Ratio
2509.22%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A